849 related articles for article (PubMed ID: 17126723)
1. Acute myeloid leukaemia.
Estey E; Döhner H
Lancet; 2006 Nov; 368(9550):1894-907. PubMed ID: 17126723
[TBL] [Abstract][Full Text] [Related]
2. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia in elderly patients: experience of a single center.
Rodrigues CA; Chauffaille ML; Pelloso LA; Ghaname FS; Kerbauy DM; Campos MG; Yamamoto M
Braz J Med Biol Res; 2003 Jun; 36(6):703-8. PubMed ID: 12792698
[TBL] [Abstract][Full Text] [Related]
4. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
6. Prospects for cure in leukaemia.
Goldman JM
J Clin Pathol; 1987 Sep; 40(9):985-94. PubMed ID: 3312307
[TBL] [Abstract][Full Text] [Related]
7. [Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment].
Wedding U; Bokemeyer C; Meran JG; ; ;
Med Klin (Munich); 2003 Apr; 98(4):193-207. PubMed ID: 12715143
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
9. Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.
Archimbaud E; Jehn U; Thomas X; De Cataldo F; Fillet G; Belhabri A; Peaud PY; Martin C; Amadori S; Willemze R
Leukemia; 1999 Jun; 13(6):843-9. PubMed ID: 10360370
[TBL] [Abstract][Full Text] [Related]
10. Adult acute myeloid leukaemia: update on treatment.
Bishop JF
Med J Aust; 1999 Jan; 170(1):39-43. PubMed ID: 10026673
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging strategies for the management of acute myeloid leukemia in the elderly.
Laubach J; Rao AV
Oncologist; 2008 Oct; 13(10):1097-108. PubMed ID: 18922830
[TBL] [Abstract][Full Text] [Related]
12. Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.
Zwaan CM; Kaspers GJ
Br J Haematol; 2004 Nov; 127(3):264-79. PubMed ID: 15491285
[TBL] [Abstract][Full Text] [Related]
13. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.
Kantarjian H; O'brien S; Cortes J; Giles F; Faderl S; Jabbour E; Garcia-Manero G; Wierda W; Pierce S; Shan J; Estey E
Cancer; 2006 Mar; 106(5):1090-8. PubMed ID: 16435386
[TBL] [Abstract][Full Text] [Related]
14. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
Kuriyama K; Tomonaga M; Matsuo T; Kobayashi T; Miwa H; Shirakawa S; Tanimoto M; Adachi K; Emi N; Hiraoka A
Br J Haematol; 1994 Apr; 86(4):767-73. PubMed ID: 7918070
[TBL] [Abstract][Full Text] [Related]
15. Optimal induction and post-remission therapy for AML in first remission.
Rowe JM
Hematology Am Soc Hematol Educ Program; 2009; ():396-405. PubMed ID: 20008225
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia.
Geissler K; Kabrna E; Stengg S; Schwarzinger I; Knöbl P; Valent P; Eichinger S; Barge A; Lechner K
Br J Haematol; 1998 Jul; 102(2):535-43. PubMed ID: 9695971
[TBL] [Abstract][Full Text] [Related]
17. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
[TBL] [Abstract][Full Text] [Related]
19. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD
J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
Tauro S; Craddock C; Peggs K; Begum G; Mahendra P; Cook G; Marsh J; Milligan D; Goldstone A; Hunter A; Khwaja A; Chopra R; Littlewood T; Peniket A; Parker A; Jackson G; Hale G; Cook M; Russell N; Mackinnon S
J Clin Oncol; 2005 Dec; 23(36):9387-93. PubMed ID: 16314618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
